Sensorimotor Training for Adults With Diabetic Peripheral Neuropathy

November 3, 2022 updated by: Universidad Complutense de Madrid

Somatosensory Restoration and Postural Control Improvement in People With Diabetic Peripheral Neuropathy Applying Sensorimotor Training: a Multicentric Randomized Controlled Trial

Adults with diabetic peripheral neuropathy tend to fall more frequently than healthy population as a consequence of multiple sensorimotor and cognitive damages. In this protocol study, a randomized controlled trial is proposed using a sensorimotor intervention based on Feldenkrais method to improve somatosensory aspects and, therefore, postural control of participants.

Study Overview

Detailed Description

Among all the systems suffering damage due to hyperglucemia toxicity in diabetes, somatosensory system, composed by proprioception and skin sensory receptors has a key role since it is in charge of the faster body reaction when a postural control response is needed. Despite of it, few studies have focused on this issue. This randomized controlled trial proposed a safe and easy training adapted to adults and old people with diabetic peripheral neuropathy. Pressure, touch, proprioception and graphesthesia sensibility were measured, as well as functionality in daily basis, quality of life and fear of falling.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: having peripheral neuropathy and history of falls or risk factors for it. Current ulcer -

Exclusion Criteria: amputation and cognitive or mental issues

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control
control arm: usual care and foot care education.
Recommendations for preventing foot ulcers
drugs and diet usual care
Experimental: experimental
experimental arm: sensorimotor training, foot care education and usual care
Recommendations for preventing foot ulcers
drugs and diet usual care
8 weeks of balance and sensorimotor training twice a week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cumulative Somatosensory Impairment Index
Time Frame: 2 years
It measures proprioception, pressure and vibration sensitivity and graphesthesia to sum up somatosensory function in lower legs. Iti is ranging from 0 to 8 being 8 the worst result
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Up and Go test
Time Frame: 2 years
postural control test
2 years
Four Square Step test
Time Frame: 2 years
ability walking in different directions
2 years
Tinetti- Performance-Oriented Mobility Assessment (POMA-T)
Time Frame: 2 years
static and dynamic postural control
2 years
Falls Efficacy Scale
Time Frame: 2 years
It measures the fear of falling, ranging from 0 to 64, being higher scores worst outcome results
2 years
SF-36 Health Survey questionnaire , 1.4 version.
Time Frame: 2 years
Quality of life health-related questionnaire
2 years
Validated Spanish version of Short-Form Late-Life Function and Disability Instrument
Time Frame: 2 years
It measures functional disabilities and frequency of daily life activities, ranging from 31 to 155 and being higher scores better outcome results.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: MARIA TERESA ANGULO CARRERA, DR, Universidad Complutense Madrid
  • Study Director: NOEMI GONZALEZ PEREZ DE VILLAR, DR, Hospital Universitario de La Paz

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

December 22, 2019

Study Completion (Actual)

January 30, 2022

Study Registration Dates

First Submitted

January 31, 2022

First Submitted That Met QC Criteria

February 21, 2022

First Posted (Actual)

March 2, 2022

Study Record Updates

Last Update Posted (Actual)

November 4, 2022

Last Update Submitted That Met QC Criteria

November 3, 2022

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Neuropathy

Clinical Trials on foot care education

3
Subscribe